Cargando…

Widespread Decreases in Cerebral Copper Are Common to Parkinson's Disease Dementia and Alzheimer's Disease Dementia

Several studies of Parkinson's disease (PD) have reported dysregulation of cerebral metals, particularly decreases in copper and increases in iron in substantia nigra (SN). However, few studies have investigated regions outside the SN, fewer have measured levels of multiple metals across differ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scholefield, Melissa, Church, Stephanie J., Xu, Jingshu, Patassini, Stefano, Roncaroli, Federico, Hooper, Nigel M., Unwin, Richard D., Cooper, Garth J. S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7966713/ https://www.ncbi.nlm.nih.gov/pubmed/33746735 http://dx.doi.org/10.3389/fnagi.2021.641222

Ejemplares similares

Severe and Regionally Widespread Increases in Tissue Urea in the Human Brain Represent a Novel Finding of Pathogenic Potential in Parkinson’s Disease Dementia
por: Scholefield, Melissa, et al.
Publicado: (2021)

Substantively Lowered Levels of Pantothenic Acid (Vitamin B5) in Several Regions of the Human Brain in Parkinson’s Disease Dementia
por: Scholefield, Melissa, et al.
Publicado: (2021)

Extensive multiregional urea elevations in a case-control study of vascular dementia point toward a novel shared mechanism of disease amongst the age-related dementias
por: Philbert, Sasha A., et al.
Publicado: (2023)

Pan-cerebral sodium elevations in vascular dementia: Evidence for disturbed brain-sodium homeostasis
por: Philbert, Sasha A., et al.
Publicado: (2022)

Widespread selenium deficiency in the brain of cases with Huntington's disease presents a new potential therapeutic target
por: Scholefield, Melissa, et al.
Publicado: (2023)

Multi-regional alterations in glucose and purine metabolic pathways in the Parkinson’s disease dementia brain
por: Scholefield, Melissa, et al.
Publicado: (2023)

Plasma metals as potential biomarkers in dementia: a case–control study in patients with sporadic Alzheimer’s disease
por: Xu, Jingshu, et al.
Publicado: (2018)

Contrasting Sodium and Potassium Perturbations in the Hippocampus Indicate Potential Na(+)/K(+)-ATPase Dysfunction in Vascular Dementia
por: Philbert, Sasha A., et al.
Publicado: (2022)

Vitamin B5 (d-pantothenic acid) localizes in myelinated structures of the rat brain: Potential role for cerebral vitamin B5 stores in local myelin homeostasis
por: Ismail, Nashwah, et al.
Publicado: (2020)

Effects of Alterations of Post-Mortem Delay and Other Tissue-Collection Variables on Metabolite Levels in Human and Rat Brain
por: Scholefield, Melissa, et al.
Publicado: (2020)

Elevation of brain glucose and polyol-pathway intermediates with accompanying brain-copper deficiency in patients with Alzheimer’s disease: metabolic basis for dementia
por: Xu, Jingshu, et al.
Publicado: (2016)

Cerebral Vitamin B5 (D-Pantothenic Acid) Deficiency as a Potential Cause of Metabolic Perturbation and Neurodegeneration in Huntington’s Disease
por: Patassini, Stefano, et al.
Publicado: (2019)

Coenzyme A-Dependent Tricarboxylic Acid Cycle Enzymes Are Decreased in Alzheimer’s Disease Consistent With Cerebral Pantothenate Deficiency
por: Sang, Crystal, et al.
Publicado: (2022)

Elevated hippocampal copper in cases of type 2 diabetes
por: Philbert, Sasha A., et al.
Publicado: (2022)

Graded perturbations of metabolism in multiple regions of human brain in Alzheimer's disease: Snapshot of a pervasive metabolic disorder
por: Xu, Jingshu, et al.
Publicado: (2016)

Are dementia with Lewy bodies and Parkinson’s disease dementia the same disease?
por: Jellinger, Kurt A., et al.
Publicado: (2018)

Cortical thinning in dementia with Lewy bodies and Parkinson disease dementia
por: Colloby, Sean J, et al.
Publicado: (2019)

The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementia
por: Schulz-Schaeffer, Walter J.
Publicado: (2010)

Relative survival in patients with dementia with Lewy bodies and Parkinson’s disease dementia
por: Larsson, Victoria, et al.
Publicado: (2018)

Diagnosis and management of Parkinson's disease dementia
por: Poewe, W, et al.
Publicado: (2008)

The Neuropathologic Substrate of Parkinson Disease Dementia
por: Jellinger, Kurt A.
Publicado: (2009)

Multivariate prediction of dementia in Parkinson’s disease
por: Phongpreecha, Thanaphong, et al.
Publicado: (2020)

Pleiotropic Effects of Variants in Dementia Genes in Parkinson Disease
por: Ibanez, Laura, et al.
Publicado: (2018)

Deficient copper concentrations in dried-defatted hepatic tissue from ob/ob mice: A potential model for study of defective copper regulation in metabolic liver disease
por: Church, Stephanie J., et al.
Publicado: (2015)

Comparing Cerebral White Matter Lesion Burdens between Parkinson’s Disease with and without Dementia
por: Choi, Sun-Ah, et al.
Publicado: (2010)

Resting state in Parkinson's disease dementia and dementia with Lewy bodies: commonalities and differences
por: Peraza, Luis R., et al.
Publicado: (2015)

Current concepts and controversies in the pathogenesis of Parkinson’s disease dementia and Dementia with Lewy Bodies
por: Weil, Rimona S., et al.
Publicado: (2017)

Parkinson’s Disease Dementia and Dementia with Lewy Bodies Have Similar Neuropsychological Profiles
por: Aldridge, Georgina M., et al.
Publicado: (2018)

CSF amyloid-β-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia
por: Bibl, Mirko, et al.
Publicado: (2006)

Dementia in Parkinsonism
Publicado: (2011)

Rivastigmine for the treatment of dementia associated with Parkinson’s disease
por: Reingold, Jennifer L, et al.
Publicado: (2007)

Can neuroimaging predict dementia in Parkinson’s disease?
por: Lanskey, Juliette H, et al.
Publicado: (2018)

Dementia and functional decline in patients with Parkinson’s disease
por: Stella, Florindo, et al.
Publicado: (2008)

Biomarkers for Dementia, Fatigue, and Depression in Parkinson's Disease
por: Prell, Tino, et al.
Publicado: (2019)

The Role of NOX4 in Parkinson’s Disease with Dementia
por: Choi, Dong-Hee, et al.
Publicado: (2019)

Neuroimaging in Parkinson’s disease dementia: connecting the dots
por: Weil, Rimona S, et al.
Publicado: (2019)

Neuroinflammation and protein pathology in Parkinson’s disease dementia
por: Kouli, Antonina, et al.
Publicado: (2020)

The Impact of Autonomic Dysfunction on Survival in Patients with Dementia with Lewy Bodies and Parkinson's Disease with Dementia
por: Stubendorff, Kajsa, et al.
Publicado: (2012)

Clinical and Neuropsychological Differences between Mild Parkinson's Disease Dementia and Dementia with Lewy Bodies
por: Petrova, Mariya, et al.
Publicado: (2015)

(18)F-AV-1451 in Parkinson’s Disease with and without dementia and in Dementia with Lewy Bodies
por: Smith, Ruben, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ottdg4jt6ggnvdkd2fk5rhbrjb